|
ISRCTN
|
ISRCTN35399995
|
|
DOI
|
10.1186/ISRCTN35399995
|
|
ClinicalTrials.gov identifier
|
|
|
EudraCT number
|
|
|
Public title
|
Treatment of good prognosis germ cell cancer
|
|
Scientific title
|
|
|
Acronym
|
N/A
|
|
Serial number at source
|
TE20
|
|
Study hypothesis
|
To compare 3 x BEP and 3 x BEP + 1 x EP and the five day schedule versus three days per cycle in good prognosis germ cell cancer
|
|
Lay summary
|
|
|
Ethics approval
|
Not provided at time of registration
|
|
Study design
|
Randomised controlled trial
|
|
Countries of recruitment
|
United Kingdom
|
|
Disease/condition/study domain
|
Testicular cancer
|
|
Participants - inclusion criteria
|
1. Seminoma or non-seminoma - testis or retroperitoneal primary, alpha-fetoprotein (AFP) ≤1000 iu/l human chorionic gonadotrophin (HCG) ≤5000 iu/l, lactic dehydrogenase (LDH) ≤1.5 x N
2. No liver, bone or brain mets seminoma - stage ≥2 C or relapse after radiotherapy and any primary site and LDH
3. No liver bone or brain mets
|
|
Participants - exclusion criteria
|
Not provided at time of registration
|
|
Anticipated start date
|
01/05/1995
|
|
Anticipated end date
|
01/05/1998
|
|
Status of trial
|
Completed |
|
Patient information material
|
|
|
Target number of participants
|
800
|
|
Interventions
|
There are four groups:
1. The first receives three cycles of BEP chemotherapy over a five day schedule
2. The second group receives three cycles of BEP + 1 cycle of EP chemotherapy over a 5 day schedule
3. The third group receives three cycles of BEP over a 3 day schedule
4. The fourth group receives three cycles of BEP over a 3 day schedule plus one cycle of EP
|
|
Primary outcome measure(s)
|
1. Time to progression
2. Quality of life
3. Morbidity
4. Survival time
|
|
Secondary outcome measure(s)
|
Not provided at time of registration
|
|
Sources of funding
|
Medical Research Council (MRC) (UK)
|
|
Trial website
|
|
|
Publications
|
1. 2001 results in http://www.ncbi.nlm.nih.gov/pubmed/11250991
2. 2003 results in http://www.ncbi.nlm.nih.gov/pubmed/12637478
|
|
Contact name
|
Mrs
Pat
Cook
|
|
Address
|
MRC Clinical Trials Unit
222 Euston Road
|
|
City/town
|
London
|
|
Zip/Postcode
|
NW1 2DA
|
|
Country
|
United Kingdom
|
|
Email
|
pat.cook@ctu.mrc.ac.uk
|
|
Sponsor
|
Medical Research Council (MRC) (UK)
|
|
Address
|
20 Park Crescent
|
|
City/town
|
London
|
|
Zip/Postcode
|
W1B 1AL
|
|
Country
|
United Kingdom
|
|
Tel
|
+44 (0)20 7636 5422
|
|
Fax
|
+44 (0)20 7436 6179
|
|
Email
|
clinical.trial@headoffice.mrc.ac.uk
|
|
Sponsor website:
|
http://www.mrc.ac.uk
|
|
Date applied
|
28/02/2001
|
|
Last edited
|
03/08/2009
|
|
Date ISRCTN assigned
|
28/02/2001
|
